Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Comment by MrMonkon Dec 08, 2015 11:01am
94 Views
Post# 24364933

RE:Final results for Marban are out

RE:Final results for Marban are outFrom Niogold IR:

The drilling has gone very well, the deposit has been mostly de-risked. The new 43-101 will likely be almost all indicated resources, meaning the next step will be evaluating economic viability (on the path to production), with an operating mine only 18 km away and easily accessible by road, our grade and hardness of rock as much as 50% better than the ore being crushed there, it all looks great for a producing mine in the near-term. When gold turns back up, we should be much higher.

Gold prices will turn up.  It moves in cycles - booms, busts, booms, busts, booms, etc.  The cycle repeats predictably - has for many, many years.  Supply is shrinking while demand is robust.  China will continue buying.  India will continue buying.  Once investor sentiment tips over, we will see gold soar again.  It's just a matter of when, and it could come sooner than you think.

-- MM
<< Previous
Bullboard Posts
Next >>